Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
NCT ID:
NCT00175916
Eligibility Criteria:
Inclusion Criteria:
* Male/female subjects from 16 years (where legally permitted and ethically accepted) or 18 years onwards suffering from epilepsy and having completed a previous study with brivaracetam as adjunctive treatment, which allowed access to this study
* Subjects with POS/PGS: inpatients or outpatients with epilepsy who participated in previous brivaracetam studies / programs which allow access to the present study
* Subjects with ULD: inpatients or outpatients with epilepsy who were treated with brivaracetam in previous studies / programs which allow access to the present study
* Subjects for whom the Investigator believes a reasonable benefit from the long-term administration of brivaracetam may be expected
Exclusion Criteria:
* Severe medical, neurological and psychiatric disorders, or laboratory values which may have an impact on the safety of the subject
* Poor compliance with visit schedule or medication intake in previous brivaracetam study
* Participation in any clinical study of another investigational drug or device during the study
* Pregnant or lactating woman
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00175916
Study Brief:
Protocol Section:
NCT00175916